Isoquinolin-1 (2H) -one derivatives as PARP-1 inhibitors

Details for Australian Patent Application No. 2010251112 (hide)

Owner NERVIANO MEDICAL SCIENCES S.r.l.

Inventors Papeo, Gianluca Mariano Enrico; Bertrand, Jay Aaron; Cervi, Giovanni; Forte, Barbara; Lupi, Rosita; Montagnoli, Alessia; Scolaro, Alessandra; Zuccotto, Fabio; Orsini, Paolo; Posteri, Helena

Agent Griffith Hack

Pub. Number AU-A-2010251112

PCT Pub. Number WO2010/133647

Priority 09160869.5 21.05.09 EP

Filing date 19 May 2010

Wipo publication date 25 November 2010

International Classifications

C07D 217/24 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

A61K 31/4725 (2006.01)

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2010/133647 Priority application(s): WO2010/133647

2 February 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 13 Dec 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010251119-Dispensing cap

2010251109-Amylase polypeptides